{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:48:11Z","timestamp":1782874091044,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.farma.2025.11.014","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T20:26:05Z","timestamp":1766780765000},"page":"273-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of digital tools and artificial intelligence in supporting antimicrobial stewardship: Study protocol for a systematic review"],"prefix":"10.1016","volume":"50","author":[{"given":"Carlos Jos\u00e9","family":"Cort\u00e9s S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Salazar Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"G\u00f3mez Portol\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Gim\u00e9nez Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Climente Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2025.11.014_bb0005","series-title":"Antibiotic resistance threats in the United States, 2013","first-page":"114","author":"CDC","year":"2013"},{"issue":"13","key":"10.1016\/j.farma.2025.11.014_bb0010","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/healthcare11131946","article-title":"Antimicrobial resistance: a growing serious threat for global public health","volume":"11","author":"Salam","year":"2023","journal-title":"Healthcare"},{"key":"10.1016\/j.farma.2025.11.014_bb0015","first-page":"84","article-title":"Tackling drug-resistant infections globally: final report and recommendations","author":"O'Neill","year":"2016","journal-title":"Rev Antimicrobial Resist"},{"key":"10.1016\/j.farma.2025.11.014_bb0020","series-title":"The bacterial challenge: time to react: a call to narrow the gap between multidrug-resistant Bacteria in the EU and the development of new antibacterial agents","author":"European Centre for Disease Prevention and Control, European Medicines Agency","year":"2009"},{"key":"10.1016\/j.farma.2025.11.014_bb0025","series-title":"Plan estrat\u00e9gico 2022\u20132024 del Plan Nacional frente a la Resistencia a los Antibi\u00f3ticos (PRAN)","author":"AEMPS","year":"2022"},{"issue":"2","key":"10.1016\/j.farma.2025.11.014_bb0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.farma.2025.11.014_bb0035","doi-asserted-by":"crossref","first-page":"33.e1","DOI":"10.1016\/j.farma.2011.10.001","article-title":"Programas de optimizaci\u00f3n de uso de antimicrobianos (PROA) en hospitales espa\u00f1oles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH","volume":"36","author":"Rodr\u00edguez-Ba\u00f1o","year":"2012","journal-title":"Farm Hosp"},{"issue":"8","key":"10.1016\/j.farma.2025.11.014_bb0040","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1128\/AAC.00825-16","article-title":"Systematic review and Meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs","volume":"60","author":"Karanika","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.farma.2025.11.014_bb0045","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1086\/678057","article-title":"Antimicrobial stewardship programs in inpatient hospital settings: a systematic review","volume":"35","author":"Wagner","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.farma.2025.11.014_bb0050","article-title":"The effect of digital antimicrobial stewardship programmes on antimicrobial usage, length of stay, mortality and cost","volume":"37","author":"Trotter","year":"2023","journal-title":"Inform Med Unlock"},{"issue":"12","key":"10.1016\/j.farma.2025.11.014_bb0055","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.sapharm.2025.07.003","article-title":"Digital educational interventions for antimicrobial stewardship: a systematic review","volume":"21","author":"Monaci","year":"2025","journal-title":"Res Soc Adm Pharm."},{"issue":"12","key":"10.1016\/j.farma.2025.11.014_bb0060","doi-asserted-by":"crossref","first-page":"e914","DOI":"10.1016\/S2589-7500(24)00198-5","article-title":"Using digital health technologies to optimise antimicrobial use globally","volume":"6","author":"Rawson","year":"2024","journal-title":"Lancet Digit Health"},{"issue":"1","key":"10.1016\/j.farma.2025.11.014_bb0065","first-page":"7","article-title":"Antimicrobial resistance crisis: Could artificial intelligence be the solution?","volume":"11","author":"Liu","year":"2024","journal-title":"Mil Med Res"},{"issue":"9","key":"10.1016\/j.farma.2025.11.014_bb0070","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/cid\/ciy907","article-title":"Infectious Diseases Society of America position statement on telehealth and telemedicine as applied to the practice of infectious diseases","volume":"68","author":"Young","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.farma.2025.11.014_bb0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.sapharm.2023.11.003","article-title":"Pharmacist insights into antimicrobial stewardship: a social marketing approach","volume":"20","author":"Hasan","year":"2024","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.farma.2025.11.014_bb0080","first-page":"1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"PRISMA-P Group","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.farma.2025.11.014_bb0085","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.farma.2025.11.014_bb0090","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.farma.2025.11.014_bb0095","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.farma.2025.11.014_bb0100","first-page":"15","article-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2014","journal-title":"Ott Ott Hosp Resea Insti"},{"issue":"4","key":"10.1016\/j.farma.2025.11.014_bb0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.farma.2025.11.014_bb0110","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/jac\/dkac112","article-title":"The impact of digital interventions on antimicrobial stewardship in hospitals: a qualitative synthesis of systematic reviews","volume":"77","author":"Van Dort","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.farma.2025.11.014_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics13040307","article-title":"Brave New World of artificial intelligence: Its use in antimicrobial stewardship\u2014a systematic review","volume":"13","author":"Pinto-de-S\u00e1","year":"2024","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.farma.2025.11.014_bb0120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000541120","article-title":"eHealth and mHealth in antimicrobial stewardship programs","volume":"8","author":"Tuon","year":"2024","journal-title":"Digit Biomark"},{"issue":"4","key":"10.1016\/j.farma.2025.11.014_bb0125","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/bcp.16001","article-title":"A tale of 2 digital hospitals: a qualitative study of antimicrobial stewardship teams","volume":"90","author":"Van Dort","year":"2024","journal-title":"Br J Clin Pharmacol"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325001771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325001771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:29:32Z","timestamp":1782872972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634325001771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1130634325001771"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2025.11.014","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of digital tools and artificial intelligence in supporting antimicrobial stewardship: Study protocol for a systematic review","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2025.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}